149 related articles for article (PubMed ID: 9723123)
1. Tiapride-induced catalepsy is potentiated by gamma-hydroxybutyric acid administration.
Navarro JF; Pedraza C; Martín M; Manzaneque JM; Dávila G; Maldonado E
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):835-44. PubMed ID: 9723123
[TBL] [Abstract][Full Text] [Related]
2. Coadministration of L-NOARG and tiapride: effects on catalepsy in male mice.
Cavas M; Navarro JF
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):69-73. PubMed ID: 11853122
[TBL] [Abstract][Full Text] [Related]
3. [Effect of tiapride on the activity of neuroleptics and other kinds of drugs in mice and rats].
Satoh H; Terai T; Nakanishi H; Ono T; Shibayama F
Nihon Yakurigaku Zasshi; 1988 Feb; 91(2):71-80. PubMed ID: 2897321
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration.
Towiwat P; Phattanarudee S; Maher TJ
Food Chem Toxicol; 2013 Jan; 51():337-42. PubMed ID: 23104245
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic-like effects of gamma-hydroxybutyrate: interactions with haloperidol and dizocilpine.
Sevak RJ; France CP; Koek W
Eur J Pharmacol; 2004 Jan; 483(2-3):289-93. PubMed ID: 14729119
[TBL] [Abstract][Full Text] [Related]
6. Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy.
Parashos SA; Marin C; Chase TN
Neurosci Lett; 1989 Oct; 105(1-2):169-73. PubMed ID: 2485878
[TBL] [Abstract][Full Text] [Related]
7. Anti-aggressive effects of GHB in OF.1 strain mice: involvement of dopamine D2 receptors.
Pedraza C; Dávila G; Martín-López M; Navarro JF
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):337-42. PubMed ID: 17050057
[TBL] [Abstract][Full Text] [Related]
8. Concentration-effect relationships for the drug of abuse gamma-hydroxybutyric acid.
Felmlee MA; Roiko SA; Morse BL; Morris ME
J Pharmacol Exp Ther; 2010 Jun; 333(3):764-71. PubMed ID: 20215411
[TBL] [Abstract][Full Text] [Related]
9. Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in mice.
Cook CD; Aceto MD; Coop A; Beardsley PM
Psychopharmacology (Berl); 2002 Feb; 160(1):99-106. PubMed ID: 11862379
[TBL] [Abstract][Full Text] [Related]
10. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
Tada M; Shirakawa K; Matsuoka N; Mutoh S
Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
[TBL] [Abstract][Full Text] [Related]
11. Nicotine potentiation of haloperidol-induced catalepsy: striatal mechanisms.
Sanberg PR; Emerich DF; el-Etri MM; Shipley MT; Zanol MD; Cahill DW; Norman AB
Pharmacol Biochem Behav; 1993 Oct; 46(2):303-7. PubMed ID: 8265684
[TBL] [Abstract][Full Text] [Related]
12. Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice.
Kasture SB; Gaikar M; Kasture V; Arote S; Salve B; Rosas M; Cotti E; Acquas E
Behav Pharmacol; 2015 Feb; 26(1-2):125-32. PubMed ID: 25144514
[TBL] [Abstract][Full Text] [Related]
13. Nicotine potentiates sulpiride-induced catalepsy in mice.
Zarrindast MR; Haeri-Zadeh F; Zarghi A; Lahiji P
J Psychopharmacol; 1998; 12(3):279-82. PubMed ID: 10958255
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic-induced catalepsy: a D2 blockade phenomenon?
Klemm WR
Pharmacol Biochem Behav; 1985 Dec; 23(6):911-5. PubMed ID: 2867564
[TBL] [Abstract][Full Text] [Related]
15. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
[TBL] [Abstract][Full Text] [Related]
16. Streptozotocin-induced diabetes differentially modifies haloperidol- and gamma-hydroxybutyric acid (GHB)-induced catalepsy.
Sevak RJ; Koek W; France CP
Eur J Pharmacol; 2005 Jul; 517(1-2):64-7. PubMed ID: 15975572
[TBL] [Abstract][Full Text] [Related]
17. Catalepsy induced by SCH 23390 in rats.
Morelli M; Di Chiara G
Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
[TBL] [Abstract][Full Text] [Related]
18. Effect of alpha-methyl-p-tyrosine on neuroleptic-induced catalepsy in rat.
Gada VP; Nandal NV; Balsara JJ; Chandorkar AG
Indian J Physiol Pharmacol; 1983; 27(3):241-4. PubMed ID: 6141998
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin antagonist potentiates haloperidol-induced catalepsy in the aged rat.
Ionov ID; Severtsev NN
Pharmacol Biochem Behav; 2012 Dec; 103(2):295-8. PubMed ID: 23036801
[TBL] [Abstract][Full Text] [Related]
20. Nicotine potentiates the behavioral effects of haloperidol.
Emerich DF; Norman AB; Sanberg PR
Psychopharmacol Bull; 1991; 27(3):385-90. PubMed ID: 1775613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
